David P. Meeker

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Boston, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ John B. Moriarty, Jr., Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for David P. Meeker

Form 4 holding President and CEO, Director

RHYTHM PHARMACEUTICALS, INC.

Security class
Restricted Stock Units
Shares / value
71,900
Estimated value
$3,647,775
Report date
11 Feb 2026
Price
$57.22
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Trevi Therapeutics, Inc.

Security class
Common Stock
Shares / value
352,489
Estimated value
$1,033,286
Report date
27 Aug 2024
Price
$2.93
Ownership
Direct
Form 4 holding Director

Trevi Therapeutics, Inc.

Security class
Nonstatutory Stock Option (right to buy)
Shares / value
35,000
Estimated value
Report date
03 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Kardigan, Inc.

Security class
Common Stock
Shares / value
20,706
Estimated value
Report date
17 Jun 2026
Price
Ownership
Direct
Form 4 holding Director

Trevi Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
27 Aug 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by David P. Meeker

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .